Chris Eso currently serves as a Member of the Board of Directors at Enterra Medical, Inc. and has held multiple leadership roles at Medtronic since August 2011, including Vice President for various divisions focusing on Corporate and Business Development, M&A, and Strategy within the Cardiovascular Portfolio. Additional advisory roles include membership on the Technical Advisory Board at Arboretum Ventures. Chris's prior experience includes positions at Peregrine Pharmaceuticals, Agilent Technologies, Watson Pharmaceuticals, and Allergan, with significant responsibilities in business operations and development. Educational qualifications include an MBA from Concordia University Irvine and a Bachelor of Arts in Communications from California State University, Fullerton.
This person is not in the org chart
This person is not in any teams
This person is not in any offices